Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study: Le cannabidiol comme traitement d'appoint de la dépression bipolaire aiguë : une étude pilote.

Autor: Pinto JV; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.; Graduate Programme in Psychiatry and Behavioural Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.; University Hospital, Federal University of Santa Catarina, Florianópolis, SC, Brazil., Crippa JAS; Department of Neuroscience and Behavioural Sciences, University of São Paulo, Ribeirão Preto, SP, Brazil.; National Institute for Science and Technology in Translational Medicine (INCT-TM), CNPq/FAPESP/CAPES, Ribeirão Preto, Brazil., Ceresér KM; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.; Graduate Programme in Psychiatry and Behavioural Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Vianna-Sulzbach MF; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.; Graduate Programme in Psychiatry and Behavioural Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Silveira Júnior ÉM; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.; Graduate Programme in Psychiatry and Behavioural Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Santana da Rosa G; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil., Testa da Silva MG; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil., Hizo GH; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.; Graduate Programme in Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Simão Medeiros L; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil., Santana de Oliveira CE; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil., Bristot G; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.; Graduate Programme in Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil., Campos AC; National Institute for Science and Technology in Translational Medicine (INCT-TM), CNPq/FAPESP/CAPES, Ribeirão Preto, Brazil.; Department of Pharmacology, University of São Paulo, Ribeirão Preto, SP, Brazil., Guimarães FS; National Institute for Science and Technology in Translational Medicine (INCT-TM), CNPq/FAPESP/CAPES, Ribeirão Preto, Brazil.; Department of Pharmacology, University of São Paulo, Ribeirão Preto, SP, Brazil., Hallak JEC; Department of Neuroscience and Behavioural Sciences, University of São Paulo, Ribeirão Preto, SP, Brazil.; National Institute for Science and Technology in Translational Medicine (INCT-TM), CNPq/FAPESP/CAPES, Ribeirão Preto, Brazil., Zuardi AW; Department of Neuroscience and Behavioural Sciences, University of São Paulo, Ribeirão Preto, SP, Brazil.; National Institute for Science and Technology in Translational Medicine (INCT-TM), CNPq/FAPESP/CAPES, Ribeirão Preto, Brazil., Yatham LN; Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada., Kapczinski F; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.; Graduate Programme in Psychiatry and Behavioural Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.; National Institute for Science and Technology in Translational Medicine (INCT-TM), CNPq/FAPESP/CAPES, Ribeirão Preto, Brazil.; Department of Psychiatry and Behavioral Neuroscience, McMaster University, Hamilton, ON, Canada., Kauer-Sant'Anna M; Laboratory of Molecular Psychiatry, Hospital de Clínicas de Porto Alegre, Porto Alegre, RS, Brazil.; Graduate Programme in Psychiatry and Behavioural Sciences, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.; Graduate Programme in Biochemistry, Federal University of Rio Grande do Sul, Porto Alegre, RS, Brazil.

Publikováno v: Canadian journal of psychiatry. Revue canadienne de psychiatrie [Can J Psychiatry] 2024 Apr; Vol. 69 (4), pp. 242-251. Date of Electronic Publication: 2023 Nov 03.

L'impact de la consommation du cannabis sur les symptômes psychiatriques : une étude transversale portant sur les troubles mentaux graves. (French)

Autor: Ziady, Hind, Beaudoin, Mélissa, Augustin, Elischa, Samson-Daoust, Eugénie, Kingsada Phraxayavong, Dumais, Alexandre

Publikováno v: Sante Mentale au Quebec; autumn2024, Vol. 49 Issue 2, p221-245, 26p

Incidence and Predictors of Cannabis-Related Poisoning and Mental and Behavioral Disorders among Patients with Medical Cannabis Authorization: A Cohort Study.

Autor: Zongo, Arsene^1,2 (AUTHOR) arsene.zongo@pha.ulaval.ca, Lee, Cerina³ (AUTHOR), Dyck, Jason R. B.⁴ (AUTHOR), El-Mourad, Jihane^1,2 (AUTHOR), Hyshka, Elaine² (AUTHOR), Hanlon, John G.^5,6 (AUTHOR), Eurich, Dean T.³ (AUTHOR)

Publikováno v: Substance Use & Misuse. 2022, Vol. 57 Issue 10, p1633-1641. 9p. 7 Charts.

Associations between cannabis use, cannabis use disorder, and mood disorders: longitudinal, genetic, and neurocognitive evidence.

Autor: Kuhns, Lauren^1,2 l.n.kuhns@uva.nl, Kroon, Emese^1,2, Colyer-Patel, Karis¹, Cousijn, Janna^1,2

Publikováno v: Psychopharmacology. May2022, Vol. 239 Issue 5, p1231-1249. 19p. 1 Diagram, 2 Charts.

Unhealthy behaviors associated with mental health disorders: a systematic comparative review of diet quality, sedentary behavior, and cannabis and tobacco use.

Autor: Johnstad, Petter Grahl

Publikováno v: Frontiers in Public Health; 2024, p01-47, 47p